FindTrial
Sign In

Research of treatment strategy and prognostic factor on glucocorticoids therapy in HBV caused acute-on-chronic liver failure patients

Research of treatment strategy and prognostic factor on glucocorticoids therapy in HBV caused acute-on-chronic liver failure patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003113
Enrollment
Unknown
Registered
2013-03-16
Start date
2013-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute-on-chronic liver failure

Interventions

intervention group:glucocorticoids therapy
control:conventional therapy

Sponsors

Beijing You'an Hospital, Capital Uedical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged from 18 to 65 years; 2. HBsAg positive; 3. acute-on-chronic liver failure according to Live Failure Guideline (Year 2006).

Exclusion criteria

Exclusion criteria: 1. with HAV or HCV or HEV infection; 2. with severe infection, gastrointestinal bleeding, Uncontrolled hypertension, diabetes mellitus, hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
survival rate;—

Countries

China

Contacts

Public ContactMeng Qing-Hua
meng_qh@sohu.com+86 13601398756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026